Current treatment landscape of pancreatic cancer patients in a network of office-based oncologists in Germany.
Future Oncol
; 2022 Dec 19.
Article
en En
| MEDLINE
| ID: mdl-36533962
Cancer of the pancreas is one of the most aggressive cancers, with poor survival despite the use of strong chemotherapy. Data from clinical practice are still rare but are the basis for understanding and improving the current standard of care. In this analysis of 24 office-based oncology practices in Germany, the authors documented treatment data of 1786 patients with pancreatic cancer who received chemotherapy between April 2017 and June 2021. The authors' analysis shows that results from recent clinical studies are promptly integrated into practice. The use of a certain type of chemotherapy with platinum increased, especially in patients younger than 70 years of age.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Future Oncol
Año:
2022
Tipo del documento:
Article
País de afiliación:
Alemania
Pais de publicación:
Reino Unido